Event Brief
UPDATED Jul 16, 2026 at 5:09 PM ET
Jul 16, 2026 at 10:04 AM ET
FDA approves Merck pill to lower 'bad' cholesterol
By The BriefBrief
The FDA approved Merck's Lipfendra, a pill intended to significantly lower LDL cholesterol.
WHO: U.S. Food and Drug Administration (FDA)
WHAT: Approved Merck's Lipfendra pill for significantly lowering LDL ('bad') cholesterol
WHEN: Jul 16, 2026 at 4:13 PM ET
WHERE: USA
WHY: Cause not yet established.
Reporting from 3 identified publishers across this event arc.
View all 3 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Pat Riley calls Antetokounmpo-Portis pairing a dream
Miami Heat
Jul 16, 2026 at 6:00 PM ET
Leavitt says election interference speech will shock America
Us
Jul 16, 2026 at 6:00 PM ET
Pillsbury recalls nearly 736,000 rolls over possible glass
Us
Jul 16, 2026 at 6:00 PM ET
Humanoid-robot fears spur strikes at Hyundai plant
World
Jul 16, 2026 at 6:00 PM ET
Page 12710 of 21463
Same format. Every time.
Continue reading — sign in or create a free account with
